Alphabet Inc. Total Cost of Revenue decreased by 9.8% to $41.27B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.5%, from $36.36B to $41.27B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 10.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $26.23B | $27.62B | $32.99B | $29.60B | $30.10B | $31.16B | $35.34B | $30.61B | $31.92B | $33.23B | $37.58B | $33.71B | $35.51B | $36.47B | $40.61B | $36.36B | $39.04B | $41.37B | $45.77B | $41.27B |
| QoQ Change | — | +5.3% | +19.4% | -10.3% | +1.7% | +3.5% | +13.4% | -13.4% | +4.3% | +4.1% | +13.1% | -10.3% | +5.3% | +2.7% | +11.3% | -10.5% | +7.4% | +6.0% | +10.6% | -9.8% |
| YoY Change | — | — | — | — | +14.8% | +12.8% | +7.1% | +3.4% | +6.0% | +6.6% | +6.3% | +10.1% | +11.3% | +9.8% | +8.1% | +7.9% | +9.9% | +13.4% | +12.7% | +13.5% |